TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04297839

Evaluation of Regional Anticoagulation With Citrate in Extended Hemodialysis

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“DUE TO CORONAVIRUS DISEASE, ACTIVITIES INTHE HOSPITAL ARE SUPRESSED”

The sponsor’s own words in the registry.

Life of this trial

2019202020212022Started2019-02-12Registered2019-10-28Suspended (as of)2021-10-05

Vital statistics

Status
Suspended
Phase
Phase 3
Sponsor
University of Sao Paulo General Hospital
Sponsor type
University, hospital or other
Conditions
Hemodialysis Complication; Acute Kidney Injury; Anticoagulant Toxicity
Interventions
Citrate Anticoagulation Solution; Control Group (heparin or continuous saline)
Participants
200 (planned, not actual)
Sites
1
Countries
Brazil

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.